Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,669.80
0.61%
Copper
4.13
(0.45%)
Oil
70.34
1.88%
Bitcoin
97,812.60
3.67%
FTSE 100
8,121.28
0.45%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.23%
Hang Seng
19,601.11
(0.23%)

Lumos Diagnostics Holdings Ltd

LDX

ASX

Lumos Diagnostics Holdings Limited (LDX) specialises in providing rapid, cost-effective, and comprehensive point-of-care diagnostic test technology. This technology aids healthcare professionals in accurately diagnosing and managing medical conditions. Lumos offers customised assay development and manufacturing services for point-of-care tests, along with proprietary digital reader platforms. Additionally, the company develops, manufactures, and commercialises its own line of Lumos-branded point-of-care tests, focusing on infectious and inflammatory diseases.

Latest Posts

Line Chart with Gradient
Price
$0.033
-0.001 (-2.94%)
At Close 20/11 (AEST)
Related Companies
ARTRYA LIMITED
$AYA
AUSTRALIAN CLINICAL LABS LIMITED
$ACL
FREEDOM CARE GROUP HOLDINGS LIMITED
$FCG
SIGMA HEALTHCARE LIMITED
$SIG
POLYNOVO LIMITED
$PNV

Leave a Comment on LDX


Comments for LDX

    Latest Posts

    lumos-diagnostics-asx-ldx-completes-retail-entitlement-offer-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) completes retail entitlement offer

    Successfully raises A$10.0 million for growth and expansion plans

    October 8, 2024
    lumos-diagnostics-asx-ldx-awarded-us2984571-barda-funding-for-febridx-clia-waiver-study-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) awarded US$2,984,571 BARDA funding for FebriDx CLIA waiver study

    BARDA partnership to expand FebriDx utility in antibiotic stewardship and point-of-care settings

    October 3, 2024
    lumos-diagnostics-asx-ldx-awarded-national-contract-with-medigroup-for-febridx-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) awarded national contract with MediGroup for FebriDx®

    FebriDx® to be available to all MediGroup members in the United States

    September 25, 2024
    lumos-diagnostics-asx-ldx-achieves-first-phase-2-milestone-in-hologic-ffn-development-agreement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) achieves first phase 2 milestone in hologic fFN development agreement

    Successfully completes milestone under phase 2 of development agreement with Hologic, Inc. for new fetal fibronectin (fFN) test

    September 20, 2024

    lumos-diagnostics-asx-ldx-appoints-thermo-fisher-scientific-as-us-distributor-for-febridx-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) appoints thermo fisher scientific as us distributor for febridx®

    Agreement with Fisher Healthcare to distribute rapid POC respiratory test in the US

    September 16, 2024

    lumos-diagnostics-asx-ldx-conducts-entitlement-offer-to-raise-a10-0-million-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) conducts entitlement offer to raise A$10.0 million

    Entitlement offer aims to fund completion of FebriDx CLIA waiver trial and expand market opportunities

    September 11, 2024

    lumos-diagnostics-asx-ldx-completes-institutional-component-of-entitlement-offer-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) completes institutional component of entitlement offer

    Raises approximately A$3.1 million from institutional and sophisticated investors

    September 6, 2024

    lumos-diagnostics-asx-ldx-requests-trading-halt-for-capital-raising-announcement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) requests trading halt for capital raising announcement

    Company requests halt for announcement on pro-rata accelerated non-renounceable entitlement offer

    September 4, 2024

    lumos-diagnostics-asx-ldx-achieves-key-phase-1-milestone-in-hologic-ffn-development-agreement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) achieves key 'phase 1 milestone' in Hologic fFN development agreement

    Completes phase 1 of Hologic fFN test development agreement valued at US$0.4 million

    May 6, 2024

    lumos-diagnostics-asx-ldx-signs-transformative-development-and-ip-agreements-with-hologic-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) signs transformative development and IP agreements with Hologic

    Reports unaudited revenue of US$4.0 million and positive cash flow for Q3 FY24

    April 24, 2024

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) completes retail entitlement offer

    Successfully raises A$10.0 million for growth and expansion plans

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) awarded US$2,984,571 BARDA funding for FebriDx CLIA waiver study

    BARDA partnership to expand FebriDx utility in antibiotic stewardship and point-of-care settings

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) awarded national contract with MediGroup for FebriDx®

    FebriDx® to be available to all MediGroup members in the United States

    Related Companies
    ALCIDION GROUP LIMITED
    $ALC
    ATOMO DIAGNOSTICS LIMITED
    $AT1
    INTELICARE HOLDINGS LIMITED
    $ICR
    SUMMERSET GROUP HOLDINGS LIMITED
    $SNZ
    RAMSAY HEALTH CARE LIMITED
    $RHC

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions